AstraZeneca PLC (AZN)

8,340.00
+58.00(+0.70%)
  • Volume:
    2,505,693
  • Bid/Ask:
    8,000.00/8,372.00
  • Day's Range:
    8,307.00 - 8,424.00

AZN Overview

Prev. Close
8,282
Day's Range
8,307-8,424
Revenue
20.18B
Open
8,334
52 wk Range
6,499.8-10,120
EPS
2.14
Volume
2,505,693
Market Cap
109.49B
Dividend (Yield)
216.00
(2.61%)
Average Volume (3m)
2,193,125
P/E Ratio
38.91
Beta
0.43
1-Year Change
1.69%
Shares Outstanding
1,312,772,156
Next Earnings Date
28 Jul 2021
What is your sentiment on AstraZeneca PLC?
or
Market is currently closed. Voting is open during market hours.

AstraZeneca PLC News

AstraZeneca PLC Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralBuyStrong BuyStrong Buy
Technical IndicatorsStrong SellSellStrong BuyStrong BuyStrong Buy
SummarySellNeutralStrong BuyStrong BuyStrong Buy

AstraZeneca PLC Company Profile

AstraZeneca PLC Company Profile

Employees
76100

AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of its SGLT2 and GLP-1 franchises in chronic kidney disease (CKD) and heart failure (HF). It has approximately 38 projects in Phase I, including 26 new molecular entities (NMEs), and 12 oncology combination projects. It has approximately 43 projects in Phase II, including 25 NMEs; six additional indications for projects that have reached phase II, and 12 oncology combination projects. It has approximately 22 projects in late-stage development, either in Phase III/pivotal Phase II studies or under regulatory review.

Read More
  • how do u start trading?
    1
    • Help
      0
  • do I invest please help
    3
    • This stock is more unpredictable than the roulette tables
      1
      • net short positions available on the PNC Borsa app
        0
        • damn
          0
          • Now is the time to go short.
            1
            • Now is the time to go short.
              0
              • love it
                0
                • 6000 is coming, time to short
                  3
                  • is night mare
                    0
                    • This stock is Toxic.
                      0
                  • What a crock- the vaccine is being done  at cost
                    0
                    • Maybe so, but there other products aren't, and it reflects on them too.
                      0
                  • Here We Go
                    0
                    • On bad news this rallied 3.5%. Today on good news it declines.
                      0
                      • they are only giving it at profit as long as it is declared a pandemic. After that will probably need annual jabs.  Weird it has gone up - they must be expecting it to be declared ok and lets Astra off hook for the shortfalls to EU at moment.  Looks like EU might have shot itself in foot, moaning about shortfalls then stopping it. Perhaps EU wanted to get its money back by saying it doesn't work. Who knows.
                        0
                        • I think both parties have break clauses in the contract. Defo politics at play with this 🤪
                          0
                        • Simon Morrisnot suprising though, hard not to be with the games the bloc is playing.
                          0
                        • US study will put that bang to rights 🤷🏼‍♂️🤪
                          0
                      • Why has this jumped on bad Vaccine News, I know they are doing it for cost but price jump don't make sense, just trying to learn.
                        0
                        • Despite of bad news share price is not going down. Today european medical council has to review. And now short selling is squeezed
                          0
                        • Canada are about to approve it for over 65’s and US are not far behind them. Unlike a few other nations they are following the science.🤪
                          0
                      • This is the time short seller are squeezed
                        0
                        • I thought it would completely collapse like 10%. But looking at the chart and PE, this has already pulled back to before covid.
                          1
                          • Unlikely as the data doesn’t supoort the coutries citing thrombrosis issues as the numbers are far less than occur normally in the community. Its just everything is being blamed on vaccines....next we will see is a flat tyre being blamed on vaccine 🤪
                            1
                          • Simon Morris  It's true, I had a flat tyre and I found out that it was the vaccine. So until I see proof that it wasn't the vaccine I am going to ride around on steel rims/hubs. It has got to be better than using that horrible old vaccine.  Europeans eh? Cant live with them can live without them. I can say that because my wife is Italian :) Actually let me just go and check that with her.
                            1
                          • Peter kurbe nice to your good lady or she might cut off the chianti 👀🤭😆
                            1
                        • 6000 is coming, time to short
                          4
                          • It's become gambling at this moment to try and predict the price movement. It is true that there are some apparent issues with their vaccines, but I expect them to sort it all out in a matter of weeks. Also, it is not like people are massively dying because of their vaccine - that would be really troublesome and would most certainly cause a bigger price collapse.
                            0
                        • This will go down more, Issues with Astrazenica Oxford Vaccines.
                          1
                          • There are no issues or we’d see numbers far in excess of the normal levels in the community. If anything the cases of clots are a lot less than occur normally 🤷🏼‍♂️
                            0
                        • Is Azn worth buying at this price or is there going to be a further drop?
                          2
                          • 03/03/21 Astrazeneca: Deutsche Bank reiterates buy with a target price of 10,000p.
                            1
                            • Is it still worth keeping AZN, when is the divident and how much it would be
                              0
                              • As I said in Jan this will touch 7000 and here we are. If it goes below then 6700 is the next stop
                                2
                                • 6700 is coming very soon
                                  0
                                • thanks what the reason for weakness ?
                                  0
                              • If i purchase the stock today, will i get the dividend?
                                2
                                • yes it goes ex div today 25th
                                  1
                                • if u bought on 24th feb, u would have made a loss, the yield wouldn't cover the capital loss. Looks bearish until next support.
                                  0
                              • The 2 charges they currently have will seriously affect the share price, l would consider buying back in if its around 6200
                                5
                                • What changes?
                                  0
                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.